Loading company…
Mitobridge is a biopharmaceutical company developing small molecule therapeutics that improve mitochondrial function.
Founded in 2011 and based in Cambridge, Massachusetts, US, Mitobridge, Inc. develops small molecule therapeutics aimed at improving mitochondrial function and treating diseases with high unmet medical need.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in